Inventor · disambiguated record
Jaymin Shah
Also filed as: SHAH JAYMIN · SHAH JAYMIN C · SHAH JAYMIN CHANDRAKANT
8 granted patents·19 pending applications·144 citations·filing 1997–2023
86Inventor score
Top patents by PatentIndex Score
27 records- 0195US6407128B1Method for increasing the bioavailability of metaxaloneELAN PHARM INC·Filed 2001·Granted Jun 18, 2002·75 cites·22 claims
- 0294US6683102B2Methods of using metaxalone in the treatment of musculoskeletal conditionsELAN PHARM INC·Filed 2002·Granted Jan 27, 2004·53 cites·15 claims
- 0389US9616055B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2015·Granted Apr 11, 2017·7 cites·17 claims
- 0484US9884056B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2017·Granted Feb 6, 2018·3 cites·16 claims
- 0583US10328068B2Oral pharmaceutical dosage formsDURECT CORP·Filed 2017·Granted Jun 25, 2019·2 cites·20 claims
- 0670US2010003331A1Sustained release dosage forms of ziprasidonePFIZER·Filed 2009·Application pending·0 cites
- 0768US10603312B2Transoral dosage forms comprising sufentanilDURECT CORP·Filed 2018·Granted Mar 31, 2020·0 cites·13 claims
- 0868US2010260844A1Oral pharmaceutical dosage formsSCICINSKI JAN J·Filed 2009·Application pending·0 cites
- 0966US2020000791A1Oral pharmaceutical dosage formsDURECT CORP·Filed 2019·Application pending·0 cites
- 1065US2020281915A1Transoral dosage forms comprising sufentanil and naloxoneDURECT CORP·Filed 2020·Application pending·0 cites
- 1161US2008293796A1Parenteral and oral formulations of benzimidazolesCHOW DIANA SHU-LIAN·Filed 2008·Application pending·0 cites
- 1261US2014011842A1Oral Pharmaceutical Dosage FormsDURECT CORP·Filed 2013·Application pending·0 cites
- 1360US2010010031A1Transoral dosage forms comprising sufentanil and naloxoneYUM II SU·Filed 2008·Application pending·0 cites
- 1459US2004142039A1Solid and semi-solid polymeric ionic conjugatesPFIZER·Filed 2003·Application pending·0 cites
- 1559US2009257975A1Solid and Semi-Solid Polymeric Ionic ConjugatesPFIZER·Filed 2009·Application pending·0 cites
- 1658US2008305161A1Injectable depot formulations and methods for providing sustained release of nanoparticle compositionsPFIZER·Filed 2008·Application pending·0 cites
- 1753US2004147532A1Liquid conjugates of solid pharmaceuticalsPFIZER·Filed 2003·Application pending·0 cites
- 1852US2008166411A1Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising NanoparticlesPFIZER·Filed 2006·Application pending·0 cites
- 1950US2016158215A1Transoral dosage forms comprising sufentanil and naloxoneDURECT CORP·Filed 2015·Application pending·0 cites
- 2048US2011002989A1Methods, dosage forms and kits for administering ziprasidone without foodPFIZER·Filed 2009·Application pending·0 cites
- 2143US2004138237A1Novel injectable depot formulationsPFIZER·Filed 2003·Application pending·0 cites
- 2243US2004146562A1Depot formulations in the form of a suspensionPFIZER·Filed 2003·Application pending·0 cites
- 2342US2006031021A1In vitro predictive methodPFIZER·Filed 2005·Application pending·0 cites
- 2442US2008193542A1Injectable Deopot Formulations and Methods For Providing Sustained Release of Nanoparticle CompositionsPFIZER·Filed 2006·Application pending·0 cites
- 2539US2024024618A1Breathwork systems and methodsYAYMIN INC·Filed 2023·Application pending·0 cites
- 2629US5891456AGlyceryl monosterate based biodegradable implants for site-specific delivery of drugsUNIV SOUTH CAROLINA·Filed 1997·Granted Apr 6, 1999·4 cites·53 claims
- 2725USD1098009SCharging caseYAYMIN INC·Filed 2023·Granted Oct 14, 2025·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Jaymin Shah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →